Company: PIII
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001832511-25-000013
Chunk: 126

Company: P3 Health Partners Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 126
---
,684)(12)(27,806)(7)Income tax provision(1,981)(1)(968)— Net loss(43,665)(13)(28,774)(7)Net loss attributable to redeemable non-controlling interest(23,303)(7)(16,754)(4)Net loss attributable to controlling interest$(20,362)(6)%$(12,020)(3)%

P3 Health Partners Inc. | Q2 2025 Form 10-Q | 31

Results of Operations

The following tables set forth our condensed consolidated statements of operations data for the periods indicated. Amounts may not sum due to rounding.

Six Months EndedJune 30, 2025% of RevenueSix Months EndedJune 30, 2024% of Revenue (dollars in thousands)Operating revenue:Capitated revenue$721,241 99 %$758,440 99 %Other patient service revenue7,772 1 9,205 1 Total operating revenue729,013 100 767,645 100 Operating expense:Medical expense723,393 99 747,228 97 Premium deficiency reserve(12,929)(2)(2,397)0 Corporate, general and administrative expense48,294 7 54,011 7 Sales and marketing expense332 0 736 0 Depreciation and amortization42,135 6 43,232 6 Total operating expense801,225 110 842,810 110 Operating loss(72,212)(10)(75,165)(10)Other (expense) income:Interest expense, net(18,870)(3)(9,692)(1)Mark-to-market of stock warrants5,324 1 8,889 1 Other901 0 628 0 Total other income (expense)(12,645)(2)(175)— Loss before income taxes(84,857)(12)(75,340)(10)Income tax provision(3,054)(0)(3,040)(0)Net loss(87,911)(12)(78,380)(10)Net loss attributable to redeemable non-controlling interest(47,069)(6)(47,660)(6)Net loss attributable to controlling interest$(40,842)(6)%$(30,720)(4)%

Comparison of the Three Months Ended June 30, 2025 and 2024

Revenue

Three Months Ended June 30